OMID (Omid Holdings) Notes Receivable: $0.00 Mil (As of . 20)


What is Omid Holdings Notes Receivable?

Omid Holdings OMID +85.75% Notes Receivable is $0.00 Mil as of . 20.

Omid Holdings's Notes Receivable for the quarter that ended in . 20 was $0.00 Mil.

Omid Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for Omid Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omid Holdings Notes Receivable Chart

Omid Holdings Annual Data
Trend
Notes Receivable

Omid Holdings Quarterly Data
Notes Receivable

Omid Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Omid Holdings (OMID) has a Notes Receivable of $0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Omid Holdings and its competitors.
Is Omid Holdings' Notes Receivable too high?
Omid Holdings' current Notes Receivable is $0.00 Mil.
How does Omid Holdings' Notes Receivable compare to competitors?
Omid Holdings' Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Omid Holdings and its competitors. Omid Holdings's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omid Holdings stock overvalued right now?
Omid Holdings (OMID) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Omid Holdings (OMID), the current Notes Receivable is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omid Holdings Business Description

Address 1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a publicly-traded health and wellness company that operates a GMP-certified manufacturing facility in Alpha, NJ. The company utilizes its strengths in research, design, development, manufacturing, and marketing to produce a types of products for its internal brands. The company also offers its services as a contract manufacturer for private label brands. With a diverse portfolio of product types, OMID specializes in formulations that contain cannabis extracts as well as other herbal ingredients. The company's objective is to provide quality, integrity, and value to its clients in all of its finished consumer goods.